Biomarkers in the brain could redefine mental health conditions

FHS
July 10, 2023
6:21 pm

The study of biomarkers in the brain-;powered by cutting-edge machine learning techniques-;could redefine the way mental health conditions are categorized and diagnosed and lead to more effective, personalized treatments.

Zevra wins FDA panel backing for previously rejected arimoclomol – Pharmaceutical Technology

The disease is caused by an accumulation of cholesterol and lipids in tissues such as the brain. Image credit: Shutterstock / Kateryna Kon. Three years

August 5, 2024

Stopping High-Efficacy MS Drugs Raises Relapse Risk for Older Patients

Patients ages 50 or older with non-active multiple sclerosis (MS) who discontinued high-efficacy therapy (HET) had a higher risk of relapse compared with those who

March 28, 2024

RoboCA3T: A novel robot-inspired computer-assisted adaptive autism therapy

A new study published in the Journal of Computer Assisted Learning introduces a novel Robot-Inspired Computer-Assisted Adaptive Autism Therapy (RoboCA3T) that leverages the natural affinity

May 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.